Valneva SE
13Patents
13Active
13Granted
51Portfolio score
Filing activity: Apr 4, 2016 → Oct 24, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10537630B2 | Virus purification | Emerging Cross-Sectional Technologies | 13 | Active |
| US10660950B2 | Virus purification | Emerging Cross-Sectional Technologies | 6 | Active |
| US11207397B2 | Virus purification | Emerging Cross-Sectional Technologies | 5 | Active |
| US11357846B2 | Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-Delta5NP3 | Emerging Cross-Sectional Technologies | 2 | Active |
| US11406700B2 | Virus purification | Emerging Cross-Sectional Technologies | 2 | Active |
| US11484587B2 | Method of producing pharmaceutical compositions comprising immunogenic Chikungunya virus CHIKV-Delta5nsP3 | Emerging Cross-Sectional Technologies | 2 | Active |
| US10662412B2 | Aseptic purification process for viruses | Chemistry; Metallurgy | 1 | Active |
| US12162909B2 | Subunit vaccine for treatment or prevention of a respiratory tract infection | Chemistry; Metallurgy | 0 | Active |
| US12162907B2 | Subunit vaccine for treatment or prevention of a respiratory tract infection | Chemistry; Metallurgy | 0 | Active |
| US11629339B2 | Aseptic purification process for viruses | Chemistry; Metallurgy | 0 | Active |
| US12011477B2 | Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-delta5NSP3 | Emerging Cross-Sectional Technologies | 0 | Active |
| US12053518B2 | Method for rescuing and producing a virus in avian cells | Chemistry; Metallurgy | 0 | Active |
| US12214033B2 | Virus purification | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.